• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经纤毛蛋白:在信号传导、血管生成及疾病中的作用

Neuropilins: role in signalling, angiogenesis and disease.

作者信息

Zachary Ian

机构信息

Centre for Cardiovascular Science and Medicine, Division of Medicine, University College London, London, UK.

出版信息

Chem Immunol Allergy. 2014;99:37-70. doi: 10.1159/000354169. Epub 2013 Oct 17.

DOI:10.1159/000354169
PMID:24217602
Abstract

Neuropilins (NRPs) are co-receptors for class 3 semaphorins and for members of the vascular endothelial growth factor (VEGF) family of angiogenic cytokines. Genetic analysis of the role of NRPs in mice shows that NRP1 is essential for embryonic neuronal pathfinding and cardiovascular development, mediated via semaphorins and VEGF, respectively, while NRP2 has a more restricted role in neuronal patterning and lymphangiogenesis. NRPs are thought to mediate functional responses, most importantly cell migration, as a result of complex formation with other receptors, such as plexins in the case of semaphorins and the VEGF receptor, VEGFR2, resulting in enhanced signalling via some intracellular pathways. Recent findings indicate that NRPs may have important biological roles in other physiological and disease-related processes. In particular, NRPs are highly expressed in diverse tumour cell lines and human neoplasms and have been implicated in several biological processes regulating tumour growth in vivo, suggesting that NRP1 may be a future therapeutic target in cancer.

摘要

神经纤毛蛋白(NRPs)是3类信号素以及血管内皮生长因子(VEGF)家族血管生成细胞因子成员的共受体。对NRPs在小鼠体内作用的遗传学分析表明,NRP1分别通过信号素和VEGF介导,对胚胎神经元寻路和心血管发育至关重要,而NRP2在神经元模式形成和淋巴管生成中的作用更为有限。NRPs被认为通过与其他受体形成复合物来介导功能反应,最重要的是细胞迁移,例如与信号素结合时与丛状蛋白形成复合物,与VEGF受体VEGFR2结合时,通过一些细胞内途径增强信号传导。最近的研究结果表明,NRPs可能在其他生理和疾病相关过程中具有重要的生物学作用。特别是,NRPs在多种肿瘤细胞系和人类肿瘤中高度表达,并参与了体内调节肿瘤生长的多个生物学过程,这表明NRP1可能是未来癌症治疗的靶点。

相似文献

1
Neuropilins: role in signalling, angiogenesis and disease.神经纤毛蛋白:在信号传导、血管生成及疾病中的作用
Chem Immunol Allergy. 2014;99:37-70. doi: 10.1159/000354169. Epub 2013 Oct 17.
2
Neuropilins: structure, function and role in disease.神经纤毛蛋白:结构、功能及在疾病中的作用
Biochem J. 2008 Apr 15;411(2):211-26. doi: 10.1042/BJ20071639.
3
New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies.神经纤毛蛋白作为共受体在肿瘤血管生成和淋巴管生成及靶向治疗策略中的新作用。
J Drug Target. 2021 Feb;29(2):155-167. doi: 10.1080/1061186X.2020.1815210. Epub 2020 Sep 3.
4
Neuropilins: novel targets for anti-angiogenesis therapies.神经纤毛蛋白:抗血管生成疗法的新靶点。
Cell Adh Migr. 2007 Apr-Jun;1(2):56-61. doi: 10.4161/cam.1.2.4490. Epub 2007 Apr 25.
5
Class 3 semaphorin in angiogenesis and lymphangiogenesis.3类信号素在血管生成和淋巴管生成中的作用
Chem Immunol Allergy. 2014;99:71-88. doi: 10.1159/000353315. Epub 2013 Oct 17.
6
Multifaceted role of neuropilins in cancer.神经钙黏蛋白在癌症中的多方面作用。
Curr Med Chem. 2011;18(23):3563-75. doi: 10.2174/092986711796642544.
7
Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.信号素在血管生成、淋巴管生成和癌症中的作用。
Cell Res. 2012 Jan;22(1):23-32. doi: 10.1038/cr.2011.198. Epub 2011 Dec 13.
8
The role of neuropilins in cell signalling.神经纤毛蛋白在细胞信号转导中的作用。
Biochem Soc Trans. 2009 Dec;37(Pt 6):1171-8. doi: 10.1042/BST0371171.
9
VEGF-A121a binding to Neuropilins - A concept revisited.VEGF-A121a 与 Neuropilins 的结合——一个被重新审视的概念。
Cell Adh Migr. 2018 May 4;12(3):204-214. doi: 10.1080/19336918.2017.1372878. Epub 2017 Nov 2.
10
Neuropilins in neoplasms: expression, regulation, and function.肿瘤中的神经纤毛蛋白:表达、调控与功能
Exp Cell Res. 2006 Mar 10;312(5):584-93. doi: 10.1016/j.yexcr.2005.11.024. Epub 2006 Jan 27.

引用本文的文献

1
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.健康与疾病中的血管内皮生长因子信号传导:从分子机制到治疗前景
Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0.
2
Neuropilin-1: A Multifaceted Target for Cancer Therapy.神经纤毛蛋白-1:癌症治疗的多面靶点
Curr Oncol. 2025 Mar 31;32(4):203. doi: 10.3390/curroncol32040203.
3
Neuropilin-1 as a Key Molecule for Renal Recovery in Lupus Nephritis: Insights from an NZB/W F1 Mouse Model.
神经纤毛蛋白 1 作为狼疮肾炎肾脏恢复的关键分子:来自 NZB/W F1 小鼠模型的见解。
Int J Mol Sci. 2024 Oct 22;25(21):11364. doi: 10.3390/ijms252111364.
4
Differentiation of Adipose Tissue Mesenchymal Stem Cells into Endothelial Cells Depends on Fat Depot Conditions: Regulation by miRNA.脂肪组织间充质干细胞向血管内皮细胞的分化取决于脂肪组织部位条件:miRNA 的调节。
Cells. 2024 Mar 14;13(6):513. doi: 10.3390/cells13060513.
5
Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice.成骨细胞中的神经纤毛蛋白 2 调节雄性小鼠的小梁骨量。
Front Endocrinol (Lausanne). 2023 Aug 1;14:1223021. doi: 10.3389/fendo.2023.1223021. eCollection 2023.
6
Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases.新生血管性眼病抗 VEGF 治疗获得性耐药的机制。
Invest Ophthalmol Vis Sci. 2023 May 1;64(5):28. doi: 10.1167/iovs.64.5.28.
7
Structural insights into regulation of CCN protein activities and functions.CCN蛋白活性与功能调控的结构解析
J Cell Commun Signal. 2023 Jun;17(2):371-390. doi: 10.1007/s12079-023-00768-5. Epub 2023 May 28.
8
Endothelial VEGFR Coreceptors Neuropilin-1 and Neuropilin-2 Are Essential for Tumor Angiogenesis.内皮 VEGFR 辅助受体神经纤毛蛋白-1 和神经纤毛蛋白-2 对于肿瘤血管生成是必需的。
Cancer Res Commun. 2022 Dec 14;2(12):1626-1640. doi: 10.1158/2767-9764.CRC-22-0250. eCollection 2022 Dec.
9
GATA3 Exerts Distinct Transcriptional Functions to Regulate Radiation Resistance in A549 and H1299 Cells.GATA3 发挥不同的转录功能以调节 A549 和 H1299 细胞的辐射抗性。
Oxid Med Cell Longev. 2022 Aug 10;2022:9174111. doi: 10.1155/2022/9174111. eCollection 2022.
10
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.人免疫缺陷病毒感染者亚临床冠状动脉疾病的蛋白质组学特征:REPRIEVE 机制子研究分析。
J Infect Dis. 2022 Nov 11;226(10):1809-1822. doi: 10.1093/infdis/jiac196.